Insiders MannKind Corporation

Equities

MNKD

US56400P7069

Market Closed - Nasdaq Other stock markets 04:00:04 2024-05-31 pm EDT			5-day change	1st Jan Change
4.675 ^USD	+3.89%		-2.20%	+28.43%

May. 29	MannKind Agrees to Cross License Deal With Pulmatrix	MT
May. 29	Pulmatrix, Inc. Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MannKind CFO Binder to Retire in April, Names New CFO	Mar. 26	MT
MannKind Corporation Appoints Steven B. Binder as Executive Vice President, Special Projects	Mar. 26	CI
Mannkind Insider Sold Shares Worth $801,928, According to a Recent SEC Filing	Dec. 18	MT
MannKind's German Manufacturing Facility Caught Fire	23-07-03	MT
MannKind Hires Burkhard Blank as CMO	23-05-24	MT
Dr. Burkhard Blank Joins MannKind Corporation as Executive Vice President of Research & Development and Chief Medical Officer	23-05-24	CI
MannKind Appoints Lauren Sabella as COO	23-03-27	MT
Lauren Sabella Joins MannKind Corporation as Executive Vice President, Chief Operating Officer	23-03-27	CI
Mannkind Corporation Announces Resignation of Alejandro Galindo as Executive Vice President – Endocrine Business Unit, Effective October 21, 2022	22-09-26	CI
MannKind Corporation Appoints James S. Shannon as the Chairman of the Board of Directors	20-12-10	CI
MannKind : Sabrina Kay Appointed to MannKind Board of Directors	20-11-30	AQ
MannKind Corporation Appoints Sabrina Kay Ed.D. to Its Board of Directors	20-11-30	CI
MannKind Corporation Announces Resignation of David Kendall as Chief Medical Officer	20-08-28	CI
Mannkind Corporation Appoints Alejandro Galindo as Chief Commercial Officer, Effective August 4, 2020	20-07-20	CI
MannKind Corporation Announces Retirement of Nordhoff from the Audit Committee and Board	20-04-10	CI
Jennifer Grancio Appointed to MannKind Board of Directors	20-03-24	GL
Jennifer Grancio Joins Mannkind's Board of Directors	20-03-24	CI
Mannkind Appoints Tony Hooper to its Board of Directors and Member of the Audit Committee, Effective January 1, 2020	19-11-21	CI
MannKind Appoints Christine Mundkur to its Board of Directors	18-11-27	CI
MannKind Corporation Appoints David M. Kendall as Chief Medical Officer, Effective February 12, 2018	18-02-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders MannKind Corporation

Equities

MNKD

US56400P7069

Insiders

Filters